BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Sergey I Pimanov, Elena V Makarenko, Alla V Voropaeva, Maya E Matveenko, Eugen V Voropaev. Helicobacter pylorieradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcerJournal of Gastroenterology and Hepatology 2008; 23(11): 1666 doi: 10.1111/j.1440-1746.2007.04983.x
Masayuki Tatemichi, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane. Clinical Significance of IgG Antibody Titer againstHelicobacter pyloriHelicobacter 2009; 14(3): 231 doi: 10.1111/j.1523-5378.2009.00681.x
J.P. Gisbert, J.M. Pajares. 13C-urea breath test in the management of Helicobacter pylori infectionDigestive and Liver Disease 2005; 37(12): 899 doi: 10.1016/j.dld.2005.09.006
Javier P. Gisbert, Xavier Calvet, Anthony OʼConnor, Francis Mégraud, Colm A. OʼMorain. Sequential Therapy for Helicobacter pylori EradicationJournal of Clinical Gastroenterology 2010; : 1 doi: 10.1097/MCG.0b013e3181c8a1a3
Efrat Broide, Haim Shirin. Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetectionExpert Review of Molecular Diagnostics 2015; 15(3): 299 doi: 10.1586/14737159.2015.982537
Bong-Ku Kang, Sung Min Park, Byung Wook Kim. New Therapeutic Strategies againstHelicobacter pyloriThe Korean Journal of Gastroenterology 2014; 63(3): 146 doi: 10.4166/kjg.2014.63.3.146
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
Muhammad Miftahussurur, Yoshio Yamaoka. Diagnostic Methods ofHelicobacter pyloriInfection for Epidemiological Studies: Critical Importance of Indirect Test ValidationBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/4819423
Toshihiro Nishizawa, Hidekazu Suzuki, Masahiko Takahashi, Masayuki Suzuki, Toshifumi Hibi. Delay of second‐line eradication therapy for H elicobacter pylori can increase eradication failure Journal of Gastroenterology and Hepatology 2013; 28(10): 1608 doi: 10.1111/jgh.12281
Jyh-Chin Yang, Chun-Jung Lin. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfectionExpert Opinion on Drug Metabolism & Toxicology 2010; 6(1): 29 doi: 10.1517/17425250903386251
Karen A. Krogfelt, Philippe Lehours, Francis Megraud. Diagnosis of Helicobacter pylori InfectionHelicobacter 2005; 10(s1): 5 doi: 10.1111/j.1523-5378.2005.00341.x
Angelo Zullo, Carola Severi, Lucy Vannella, Cesare Hassan, Andrea Sbrozzi-Vanni, Bruno Annibale. Role of gastritis pattern on Helicobacter pylori eradicationInternal and Emergency Medicine 2012; 7(6): 517 doi: 10.1007/s11739-011-0730-4
Ki Bang Kim, Yong Sik Kim. Recent Trends ofHelicobacter pyloriEradication Therapy: Focusing on First Line TreatmentThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014; 14(4): 237 doi: 10.7704/kjhugr.2014.14.4.237
György M. Buzás, Ilona Széles. Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infectionJournal of Gastroenterology 2008; 43(2): 108 doi: 10.1007/s00535-007-2135-8
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert, Javier P Gisbert. Cochrane Database of Systematic Reviews2011;  doi: 10.1002/14651858.CD009034
V. De Francesco, A. Zullo, E. Ierardi, F. Giorgio, F. Perna, C. Hassan, S. Morini, C. Panella, D. Vaira. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limitsJournal of Antimicrobial Chemotherapy 2010; 65(2): 327 doi: 10.1093/jac/dkp445
Hyuk Yoon. Helicobacter pylori2016; : 447 doi: 10.1007/978-981-287-706-2_43
J.P. Gisbert, D. Olivares, I. Jimenez, J.M. Pajares. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?Digestive and Liver Disease 2006; 38(4): 254 doi: 10.1016/j.dld.2005.10.022
J. P. Gisbert, X. Calvet. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pyloriAlimentary Pharmacology & Therapeutics 2011; 34(6): 604 doi: 10.1111/j.1365-2036.2011.04770.x
Ju Yup Lee. Helicobacter pylori2016; : 427 doi: 10.1007/978-981-287-706-2_41
Javier P Gisbert, Xavier Calvet, JP Anthony O'Connor, Francis Mégraud, Colm A O'Morain. The sequential therapy regimen forHelicobacter pylorieradicationExpert Opinion on Pharmacotherapy 2010; 11(6): 905 doi: 10.1517/14656561003657152
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradicationCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD009034.pub2
Kee Don Choi. Current Trends ofHelicobacter pyloriEradication in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3): 147 doi: 10.7704/kjhugr.2015.15.3.147
Su Young Kim, Dong Kyun Park, Kwang An Kwon, Kyoung Oh Kim, Yoon Jae Kim, Jun Won Chung. Ten Day Concomitant Therapy Is Superior to Ten Day Sequential Therapy forHelicobacter pyloriEradicationThe Korean Journal of Gastroenterology 2014; 64(5): 260 doi: 10.4166/kjg.2014.64.5.260
Y. S. Kim, S. J. Kim, J. H. Yoon, K. T. Suk, J. B. Kim, D. J. Kim, D. Y. Kim, H. J. Min, S. H. Park, W. G. Shin, K. H. Kim, H. Y. Kim, G. H. Baik. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in KoreaAlimentary Pharmacology & Therapeutics 2011; 34(9): 1098 doi: 10.1111/j.1365-2036.2011.04843.x
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan. Predicting Helicobacter pylori EradicationJournal of Clinical Gastroenterology 2012; 46(4): 259 doi: 10.1097/MCG.0b013e318247177e
Jong In Kim, Byung-Wook Kim. Sequential Therapy ofHelicobacter pyloriInfectionThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011; 11(2): 103 doi: 10.7704/kjhugr.2011.11.2.103
Toshihiro Nishizawa, Hidekazu Suzuki, Tatsuhiro Masaoka, Eisuke Iwasaki, Toshifumi Hibi. A New Eradication Resistance Index as a Predictor of Metronidazole-Containing Second-Line Treatment of <i>Helicobacter pylori</i>Digestion 2007; 76(3-4): 215 doi: 10.1159/000112649
Angelo Zullo, Federico Perna, Chiara Ricci, Cesare Hassan, Andrea Tampieri, Vincenzo De Francesco, Sergio Morini, Dino Vaira. 13C-Urea Breath Test Values and Helicobacter pylori EradicationDigestive Diseases and Sciences 2008; 53(2): 370 doi: 10.1007/s10620-007-9893-2